Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Mansi

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
ChlVPP: reducing toxicity in the treatment of Hodgkin's diseaseJ L Mansi
British Journal of Hospital Medicine|July 10, 1996
Adjuvant treatment in high-risk breast cancerJ L Mansi
Cancer Treatment Reviews|November 1, 1996
New drugs. The anthrapyrazolesH Gogas, J L Mansi
Current Medical Research and Opinion|September 21, 2002
The role of bisphosphonates in breast cancer management: review articleL M Pickering, J L Mansi
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1995
Oesophageal varices: a potentially fatal complication of liver metastasesT R Evans, J L Mansi
Lancet (London, England)|July 1, 1989
Drainage of malignant effusionsJ L Mansi, G W Hanks
Annals of the Royal College of Surgeons of England|March 1, 1995
Adjuvant chemotherapy for colorectal cancerZ Rayter, R J Leicester, J L Mansi
Cancer|February 15, 1989
Prolonged survival in a patient with disseminated malignant teratoma in the presence of a persistently elevated serum alpha-fetoprotein levelC S Lawson, J L Mansi, E Wiltshaw
Cancer Chemotherapy and Pharmacology|January 1, 1990
Ifosfamide with and without adriamycin in advanced uterine leiomyosarcomaR E Hawkins, E Wiltshaw, J L Mansi
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Management of adenocarcinoma of unknown primary with a 5-fluorouracil-cisplatin chemotherapy regimen (CFTam)F J Lofts, H Gogas, J L Mansi
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
ChlVPP: reducing toxicity in the treatment of Hodgkin's diseaseJ L Mansi
British Journal of Hospital Medicine|July 10, 1996
Adjuvant treatment in high-risk breast cancerJ L Mansi
Cancer Treatment Reviews|November 1, 1996
New drugs. The anthrapyrazolesH Gogas, J L Mansi
Current Medical Research and Opinion|September 21, 2002
The role of bisphosphonates in breast cancer management: review articleL M Pickering, J L Mansi
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1995
Oesophageal varices: a potentially fatal complication of liver metastasesT R Evans, J L Mansi
Lancet (London, England)|July 1, 1989
Drainage of malignant effusionsJ L Mansi, G W Hanks
Annals of the Royal College of Surgeons of England|March 1, 1995
Adjuvant chemotherapy for colorectal cancerZ Rayter, R J Leicester, J L Mansi
Cancer|February 15, 1989
Prolonged survival in a patient with disseminated malignant teratoma in the presence of a persistently elevated serum alpha-fetoprotein levelC S Lawson, J L Mansi, E Wiltshaw
Cancer Chemotherapy and Pharmacology|January 1, 1990
Ifosfamide with and without adriamycin in advanced uterine leiomyosarcomaR E Hawkins, E Wiltshaw, J L Mansi
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Management of adenocarcinoma of unknown primary with a 5-fluorouracil-cisplatin chemotherapy regimen (CFTam)F J Lofts, H Gogas, J L Mansi
Pageof 6